TrialBreast cancer research and treatment2009

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).

G G Kimmick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.